+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Connected Drug Delivery Devices Market Analysis Report By Technology (Bluetooth, NFC), By Product (Connected Sensors, Integrated Connected Devices), By End User, And Segment Forecasts, 2018 - 2025

  • ID: 4751775
  • Report
  • 85 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Adherium Limited
  • BIOCORP
  • Merck KGaA
  • Propeller Health
  • Proteus Digital Health
  • MORE
The global connected drug delivery devices market size is expected to reach USD 717.7 million by 2025. The market is projected to expand at a strong CAGR of 25.1% during the forecast period. Factors contributing to the growth of this market include rise in awareness regarding adverse effects of non-adherence to medication and increased adoption of IoT, patient connectivity, and engagement. Based on the product type, connected drug delivery systems are categorized as sensors and integrated devices.

The sensors segment accounted for the largest market share of 72.6% in 2017. The connected sensors are cost-effective as compared to their integrated counterparts. Moreover, the cost of switching from a conventional systems to add-on sensors is low. The integrated systems are anticipated to witness the fastest CAGR over the forecast period owing to reduced prices of these devices. These devices also provide more detailed insights regarding the dosage and patient’s compliance and health records, which is expected to drive their demand further.

North America held the largest revenue share at 34.4% and will continue to retain its leading position over the forecast period. Quick adoption of advanced devices and technologies and high per capita healthcare expenditure are expected to boost the demand for connected drug delivery systems in the region. Some of the key companies in the global connected drug delivery device market include Propeller Health; Proteus Digital Health, Inc.; Adherium Limited; BIOCORP; and Merck KGaA.

Further key findings from the study suggest:
  • The connected sensors segment led the market in terms of revenue share in 2017. Cost-effectiveness and easy availability of these sensors were the major factors behind the segment growth
  • The Bluetooth technology was the largest technology segment in 2017 and accounted for 70.5% of the global market share
  • The homecare segment is anticipated to witness the fastest CAGR of 26.9% owing to increasing shifting preference for homecare settings or Point of Contact (PoC)
  • North America led the market in 2017 owing to the presence of a large number of early adopters and high per capita healthcare expenditure
  • Some of the key companies in the global connected drug delivery devices market are Propeller Health, Proteus Digital Health, Adherium Ltd., BIOCORP, and Merck KGaA.


Please Note: This report will be delivered within 48 hours of ordering.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Adherium Limited
  • BIOCORP
  • Merck KGaA
  • Propeller Health
  • Proteus Digital Health
  • MORE
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope and Assumptions
1.3 List to Data Sources

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Global Connected Drug Delivery Devices Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Market Driver Analysis
3.2.1 Increased patient connectivity and engagement
3.2.2 Rising patient awareness about adherence to prescribed therapies
3.3 Market Restraint Analysis
3.3.1 Increased cost of devices
3.3.2 Increasing concerns about data privacy and transfer
3.4 Market - SWOT Analysis, by Factor (Political & legal, Economic and Technological)
3.5 Industry Analysis - Porter’s

Chapter 4 Global Connected Drug Delivery Devices Market: Product Estimates & Trend Analysis
4.1 Global Connected Drug Delivery Devices Market: Product Movement Analysis
4.2 Connected Sensors
4.2.1 Market Estimates and Forecasts, 2014 - 2025 (USD Million)
4.2.2 Connected Inhaler Sensors
4.2.2.1 Market Estimates and Forecasts, 2014 - 2025 (USD Million)
4.2.3 ConnecTable Injection Sensors
4.2.4 Market Estimates and Forecasts, 2014 - 2025 (USD Million)
4.3 Integrated Connected Devices
4.3.1 Market Estimates and Forecasts, 2014 - 2025 (USD Million)
4.3.2 Connected Inhalation Devices
4.3.2.1 Market Estimates and Forecasts, 2014 - 2025 (USD Million)
4.3.3 Connected Injection Devices
4.3.4 Market Estimates and Forecasts, 2014 - 2025 (USD Million)

Chapter 5 Global Connected Drug Delivery Devices Market: End-user Estimates & Trend Analysis
5.1 Global Connected Drug Delivery Devices Market: End-use Movement Analysis
5.2 Healthcare Providers
5.2.1 Market estimates and forecasts in healthcare providers Segment, 2014 - 2025 (USD Million)
5.3 Homecare Centers
5.3.1 Market estimates and forecasts in homecare segment, 2014 - 2025 (USD Million)

Chapter 6 Global Connected Drug Delivery Devices Market: Technology Estimates & Trend Analysis
6.1 Global Connected Drug Delivery Devices Market: Technology Movement Analysis
6.2 Bluetooth
6.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
6.3 NFC
6.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
6.4 Other Technologies
6.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 7 Global Connected Drug Delivery Devices Market: Regional Estimates & Trend Analysis, By Product, Technology, and End-use
7.1 Global Connected Drug Delivery Devices Market: Regional Movement Analysis
7.2 North America
7.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
7.2.2 U.S.
7.2.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
7.3 Europe
7.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
7.3.2 U.K.
7.3.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
7.3.3 Germany
7.3.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
7.4.2 Japan
7.4.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
7.4.3 China
7.4.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
7.5.3 Mexico
7.5.3.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
7.6 MEA
7.6.1 Market estimates and forecasts, 2014 - 2025 (USD Million)
7.6.2 South Africa
7.6.2.1 Market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 Propeller Health
8.1.1.1 Company overview
8.1.1.2 Product benchmarking
8.1.1.3 Strategic initiatives
8.1.2 BIOCORP
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3 Proteus Digital Health
8.1.3.1 Company overview
8.1.3.2 Product benchmarking
8.1.3.3 Strategic initiatives
8.1.4 Merck KGaA
8.1.4.1 Company overview
8.1.4.2 Financial performance
8.1.4.3 Product benchmarking
8.1.4.4 Strategic initiatives
8.1.5 Adherium Limited
8.1.5.1 Company overview
8.1.5.2 Financial performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic initiatives
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Propeller Health
  • BIOCORP
  • Proteus Digital Health
  • Merck KGaA
  • Adherium Limited
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4751775
Adroll
adroll